Biodexa Pharmaceuticals Plc (NASDAQ:BDRX - Get Free Report)'s share price rose 6.9% during trading on Thursday . The stock traded as high as $1.93 and last traded at $1.39. Approximately 62,690,079 shares changed hands during mid-day trading, an increase of 7,495% from the average daily volume of 825,372 shares. The stock had previously closed at $1.30.
Biodexa Pharmaceuticals Stock Down 6.5%
The firm's 50-day moving average is $1.43 and its 200 day moving average is $3.17.
About Biodexa Pharmaceuticals
(
Get Free Report)
Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.
Recommended Stories
Before you consider Biodexa Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Biodexa Pharmaceuticals wasn't on the list.
While Biodexa Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
